Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label, single dose study designed to assess the pharmacokinetics and safety
of ABT-493 and ABT-530 in subjects with either normal renal function or impaired renal
function.